Search Tag: TAVI

Cardiology Management


2015 24 May

According to new data released at EuroPCR 2015, thickening of the valve leaflets following implantation of a transcatheter or surgical aortic valve bioprosthesis is relatively rare and is not linked to short-term clinical events or unique to any one type of valve. In a special session devoted to this topic, experts recommend that while there is a need...Read more

Cardiology Management


2016 17 May

New reports from EuroPCR 2016 reveal that half of transcatheter heart valves undergo degeneration within 10 years. Findings from the first study to investigate the long-term durability of these valves were presented at the congress. TAVI has now become increasingly popular among younger patients as well as those with lower surgical risk. Life expectancy...Read more

Cardiology Management


2016 07 Nov

A systematic review and meta-analysis published in British Medical Journal , examines the effect of TAVI versus surgical replacement of an aortic valve (SAVR) in patients with severe aortic stenosis at low and intermediate risk of perioperative death and reviews on the values and preferences of patients.   TAVI has been increasingly used as...Read more

Cardiology Management


2017 07 Mar

When transcatheter aortic valve implantation (TAVI) was introduced in 2002, it was proposed as a therapy for inoperable or very high risk patients. Recently, the procedure has also been performed on younger lower risk persons with less comorbidities. The evolution in the indication for TAVI might be regarded as a model for the uptake of a new therapy,...Read more

Health Management


2017 07 May

Cholesterol Lowering (R)evolution, TAVI and More... The latest cardiology research was presented at the American College of Cardiology meeting: transcatheter valve implants emerge as an alternative in less than high risk severe aortic stenosis patients; can iFR define whether your coronary artery requires a stent? Extremely low LDL-cholesterol levels...Read more

Health Management


2018 21 Aug

In this issue of HealthManagement, we shine the spotlight on two leading figures in the field of cardiology—Prof. Dr. Hüseyin Ince and Dr. Giuseppe D'Ancona—to bring together their expert views on key developments in transcatheter aortic valve implantation (TAVI), percutaneous mitral valve repair and more. Transcatheter aortic valve implantation...Read more

Cardiology Management


2019 16 Jan

There has been significant advancement in the field of computed tomography imaging and transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). Technological advancement and data supporting the use of TAVI/TAVR have resulted in a deep integration of TAVI/TAVR and CT imaging in clinical practice. TAVI/TAVR is...Read more

Cardiology Management


2021 28 Aug

In another Hot Line session at the ESC Congress 2021, findings from the ENVISAGE-TAVI AF showed that edoxaban is non-inferior to warfarin and its analogues for adverse clinical events in patients with atrial fibrillation after transcatheter aortic valve implantation.   The prevalence of pre-existing or new-onset atrial fibrillation after TAVI ranges...Read more